​Infectious Disease And Microbiology – Endocarditis (Prosthetic Valve)


Prosthetic valve endocarditis is an infection involving prosthetic heart valves or associated prosthetic material. It is most commonly caused by bacteria, especially Gram-positive organisms, although fungi and, rarely, organisms such as chlamydiae or rickettsiae may also be responsible. This form of endocarditis is a serious complication of valve replacement and can arise either early after surgery or later through bloodstream spread from another infectious source.


The incidence of prosthetic valve infective endocarditis is approximately 0.3–1% per patient-year. The most important risk factors are healthcare-associated infections, chronic intravascular access, and hemodialysis. Additional predisposing factors include the presence of prosthetic valve material itself and any circumstances that increase the likelihood of bloodstream infection.


Prevention includes antibiotic prophylaxis for high-risk patients, particularly before dental procedures that involve manipulation of gingival tissue or disruption of the oral mucosa. Prophylaxis is also considered reasonable for certain respiratory, skin, soft tissue, or muscle procedures in those at highest risk. Recommended prophylactic regimens include a single dose of amoxicillin 2 g or clindamycin 600 mg administered 30–60 minutes before the procedure. Antibiotic prophylaxis is not recommended for gastrointestinal or genitourinary procedures.


The pathophysiology of prosthetic valve endocarditis involves contamination during implantation, later hematogenous seeding of the prosthesis, or contiguous spread of nearby infection. Staphylococci are the most common causes. Early-onset prosthetic valve endocarditis, occurring within 60 days of surgery, is more often due to hospital-acquired pathogens, whereas late-onset infection is caused by organisms more similar to those seen in native valve endocarditis. Early infections are commonly caused by Staphylococcus aureus, coagulase-negative staphylococci, enterococci, Gram-negative bacilli, fungi, and occasionally streptococci. Late infections are more often caused by S. aureus, coagulase-negative staphylococci, streptococci, enterococci, fungi, and Gram-negative bacilli. Culture-negative cases may occur, most often after recent antibiotic exposure or with fastidious organisms such as Bartonella, Coxiella burnetii, Brucella, or Tropheryma whipplei.


The clinical presentation is highly variable. Some patients present with an acute toxic illness and high fever, whereas others have a more indolent subacute course. In any patient with a prosthetic valve and unexplained fever, endocarditis must be strongly considered. Fever is present in more than 70% of cases, and other symptoms may include weakness, chills, sweats, anorexia, weight loss, nausea, and malaise. A careful history should also explore travel, animal exposure, and consumption of unpasteurized dairy products, which may suggest unusual pathogens.


Diagnosis is commonly based on the modified Duke criteria, which combine clinical, microbiologic, and echocardiographic data. Major criteria include persistently positive blood cultures for typical organisms and evidence of endocardial involvement, such as vegetations, abscesses, prosthetic valve dehiscence, or new valvular regurgitation. Minor criteria include predisposition, fever, vascular phenomena, immunologic phenomena, and microbiologic findings that do not meet major criteria.


On physical examination, patients may have a new or changed murmur or signs of congestive heart failure. Because embolic and metastatic complications are common, a full examination should assess for neurologic deficits, splenic involvement, spinal tenderness, joint infection, or other distant sites of disease.


Initial laboratory workup includes complete blood count, electrolytes, renal and liver function tests, inflammatory markers, urinalysis, and multiple blood cultures. At least three sets of blood cultures should be obtained within the first 24 hours before starting antibiotics. The first two sets are positive in most patients. Leukocytosis and elevated ESR or CRP are common. In culture-negative cases, serologic testing for organisms such as Coxiella burnetii and Bartonella should be considered. Blood cultures should be repeated every 24–48 hours until the infection has cleared.


Transesophageal echocardiography is the imaging test of choice because prosthetic valves often create artifact on transthoracic studies and because prosthetic valve infections frequently involve paravalvular complications. TEE has high sensitivity and specificity for detecting vegetations, abscesses, and dehiscence and should be performed as soon as possible when prosthetic valve endocarditis is suspected. Additional imaging of the brain, lungs, abdomen, or spine may be needed if embolic events, abscesses, or mycotic aneurysms are suspected. Electrocardiography is also important to detect baseline or evolving conduction abnormalities, which may indicate abscess extension.


Treatment requires prolonged bactericidal intravenous antibiotic therapy, with regimens tailored to the causative organism and its susceptibilities. For streptococcal infections, treatment typically includes penicillin G or ceftriaxone plus gentamicin, with vancomycin used in selected allergic patients. For enterococci or highly penicillin-resistant streptococci, ampicillin plus gentamicin is commonly used, or vancomycin plus gentamicin if ampicillin cannot be given. Methicillin-susceptible staphylococcal infections are treated with nafcillin plus rifampin for at least six weeks, with gentamicin added for the first two weeks. Methicillin-resistant staphylococcal infections are treated with vancomycin plus rifampin for at least six weeks, again with gentamicin for two weeks. Rifampin is often delayed by a few days because resistance can develop quickly if started too early.


Management requires a multidisciplinary approach involving cardiology, infectious diseases, and cardiovascular surgery. Patients with prosthetic valve endocarditis should be evaluated early for surgery. Valve replacement may be necessary in cases of prosthetic valve dehiscence, perforation, fistula formation, large abscess, severe structural damage, or failure of medical therapy because of highly resistant organisms.


All patients require hospitalization for monitoring, intravenous therapy, and expedited evaluation. They may be discharged once fevers have resolved for more than 24 hours, vital signs are stable, and a safe plan for continued antibiotic treatment and follow-up is in place. During and after therapy, patients should be monitored closely for relapse, treatment complications, and new cardiac dysfunction. At completion of therapy, transthoracic echocardiography is recommended to establish a new baseline for valve and cardiac function.


Patient education is important and should include the importance of good oral hygiene, prevention of future endocarditis associated with dental procedures, and recognition of symptoms of valvular dysfunction. Prognosis depends on several factors. Higher mortality is associated with healthcare-associated infection, congestive heart failure, older age, S. aureus infection, persistent bacteremia, stroke, and intracardiac abscess. In-hospital mortality is substantial. Complications include periprosthetic leak, ring abscess, congestive heart failure, cerebral emboli, stroke, renal infarction, immune complex glomerulonephritis, mycotic aneurysm, meningitis, cerebritis, splenic infarction or abscess, heart block, and pulmonary embolism in right-sided disease.

Infectious Disease and Microbiology: Fungal Infections of the Hair, Skin, and Nails (Dermatophytosis / Tinea)




Fungal infections of the hair, skin, and nails—collectively known as dermatophytosis or tinea—are common infectious diseases affecting keratinized tissues. These infections are caused by dermatophyte fungi that invade the superficial layers of the skin, hair, or nails through enzymes such as keratinases. They are classified based on the site of infection, including tinea pedis (feet), tinea corporis (body), tinea cruris (groin), tinea capitis (scalp), and onychomycosis (nails). These infections occur worldwide and are particularly common in hot and humid climates.


Epidemiologically, dermatophytosis affects different populations depending on the type. Tinea capitis is most common in children, while tinea pedis is more frequently seen in young adult males. Onychomycosis is the most common nail disorder in adults. Risk factors include excessive moisture, tight clothing, poor hygiene, diabetes mellitus, obesity, and immunosuppression. Transmission occurs through direct contact with infected individuals, animals, or contaminated objects such as towels, footwear, and communal shower surfaces.


The pathophysiology involves fungal invasion of keratinized structures such as the stratum corneum, hair shafts, and nail beds. The fungi proliferate outward, producing characteristic ring-shaped lesions with central clearing in skin infections. In scalp infections, the hair becomes brittle and breaks, resulting in patches of alopecia. Nail infections lead to thickened, discolored, and brittle nails. The host immune response contributes to inflammation, scaling, and itching, while also attempting to contain the infection.


Clinically, the presentation varies according to the site involved. Tinea pedis typically presents with itching, scaling, and fissuring between the toes. Tinea corporis manifests as circular, erythematous, scaly lesions with raised borders. Tinea cruris causes an itchy rash in the groin area. Tinea capitis presents with scalp scaling, hair loss, and sometimes pustules. Onychomycosis results in thickened, discolored, and brittle nails. Secondary bacterial infection may complicate some cases, especially in tinea pedis.


Diagnosis is usually established by microscopic examination of skin scrapings, hair, or nail samples using potassium hydroxide preparation. Fungal cultures on specialized media can confirm the diagnosis, and Wood’s lamp examination may assist in detecting certain species. Advanced techniques such as polymerase chain reaction may be used in specialized settings.


Treatment depends on the severity and location of the infection. Most superficial infections respond to topical antifungal agents such as Terbinafine, tolnaftate, or undecylenic acid. Oral antifungal therapy, including Griseofulvin or Ketoconazole, is required for more extensive disease, scalp involvement, or nail infections. Onychomycosis typically requires prolonged treatment. Preventive measures such as maintaining hygiene, keeping skin dry, avoiding sharing personal items, and using protective footwear in communal areas are important to prevent recurrence.


The prognosis is generally excellent with appropriate treatment, although recurrence is common if predisposing factors persist. Complications are uncommon but may include secondary bacterial infections, chronic disease, and, in severe scalp infections, permanent hair loss. Early diagnosis and adherence to therapy are essential for successful management.

​

Infectious Disease And Microbiology – Food-Borne Diseases




Food-borne diseases are illnesses that result from ingestion of food contaminated by pathogenic microorganisms, microbial toxins, or chemical substances. They are extremely common and represent a major public health problem. In the United States alone, it has been estimated that more than 75 million episodes occur annually. Outbreaks are most often caused by noroviruses, followed by Salmonella. Infants, older adults, and immunocompromised individuals are at particularly high risk for severe disease. Some pathogens also have specific risk groups; for example, Vibrio vulnificus infection is more common and more severe in patients with chronic liver disease or other forms of immunosuppression.


Prevention is centered on safe food handling and avoidance of high-risk foods. Raw or undercooked eggs, unpasteurized dairy products, raw or undercooked meat, poultry, and seafood, as well as soft cheeses, should be avoided when possible. Cross-contamination during food preparation should be prevented, and handwashing before handling food is essential. Vaccination also plays a role in prevention, particularly hepatitis A immunization and infant vaccination against rotavirus.


The causes of food-borne illness are broad and include bacterial, viral, parasitic, and noninfectious toxins. Bacterial causes include Salmonella, Shigella, enterohemorrhagic and enterotoxigenic Escherichia coli, Campylobacter jejuni, Vibrio species, Yersinia species, Clostridium perfringens, Staphylococcus aureus, Bacillus cereus, Clostridium botulinum, and Listeria monocytogenes. These organisms are associated with particular foods such as poultry, eggs, shellfish, contaminated water, undercooked beef, rice, canned foods, and unpasteurized dairy products. Viral agents include norovirus, rotavirus, and hepatitis A virus, while parasites include Giardia lamblia, Entamoeba histolytica, Cryptosporidium, and Cyclospora cayetanensis. Noninfectious causes include marine toxins such as ciguatera toxin, scombroid toxin, tetrodotoxin, shellfish toxins, as well as heavy metals, mushroom toxins, pesticides, and certain food additives such as monosodium glutamate.


The clinical presentation depends on the causative agent. Bacterial infections often present with diarrhea, abdominal cramps, fever, nausea, and vomiting, although the exact pattern varies. Salmonella commonly causes diarrhea, fever, and cramps, while Shigella often produces bloody, mucus-containing stools. Enterohemorrhagic E. coli typically causes severe abdominal pain and bloody diarrhea with little or no fever. Campylobacter may cause bloody diarrhea and fever, while cholera presents with profuse watery diarrhea leading to dehydration. Preformed toxin illnesses such as those caused by Staphylococcus aureus and the emetic type of Bacillus cereus produce abrupt, intense vomiting within hours of ingestion. Clostridium botulinum causes gastrointestinal symptoms followed by neurologic signs such as blurred vision, diplopia, dysphagia, and descending paralysis.


Viral food-borne diseases commonly cause acute gastroenteritis. Norovirus produces nausea, vomiting, cramping, diarrhea, low-grade fever, and myalgias, with vomiting more common in children and diarrhea more common in adults. Rotavirus causes vomiting and watery diarrhea, especially in young children. Hepatitis A has a much longer incubation period and presents with jaundice, dark urine, flu-like symptoms, and sometimes diarrhea.


Parasitic infections tend to have more prolonged courses. Giardia causes diarrhea, gas, and abdominal cramps that may last weeks to months. Entamoeba histolytica often causes bloody diarrhea and lower abdominal pain. Cryptosporidium usually causes watery diarrhea and cramps, while Cyclospora often causes prolonged watery diarrhea with nausea, anorexia, and weight loss.


Noninfectious food-borne toxins often produce rapid symptom onset. Ciguatera poisoning causes gastrointestinal symptoms followed by neurologic manifestations such as paresthesias and reversal of hot and cold sensation, and sometimes cardiovascular effects such as bradycardia and hypotension. Scombroid poisoning causes flushing, rash, urticaria, dizziness, and paresthesias shortly after eating affected fish. Tetrodotoxin from puffer fish causes rapid neurologic symptoms, ascending paralysis, and respiratory failure. Shellfish toxins may cause diarrheal, neurotoxic, amnesic, or paralytic syndromes depending on the toxin involved.


Physical examination usually focuses on assessing dehydration and abdominal findings. Signs such as dry mucous membranes, reduced urine output, tachycardia, and hypotension suggest volume depletion. Abdominal tenderness may be present. In Vibrio vulnificus infection, bullous skin lesions may occur.


Diagnosis depends on the suspected cause. Stool culture is useful for Salmonella, Shigella, Campylobacter, certain E. coli strains, Vibrio, and Yersinia, although special media are needed for some of these organisms. Clostridium botulinum diagnosis relies on testing stool, serum, or food for toxin. Viral illnesses such as norovirus are often diagnosed clinically, while rotavirus can be identified by stool immunoassay and hepatitis A by positive IgM antibody. Parasitic infections are diagnosed by stool examination for ova, cysts, or parasites, or by enzyme immunoassays. Toxin-mediated illnesses may require toxin assays, chromatography, or histamine detection in food.


Treatment for most food-borne illnesses is supportive, with fluid and electrolyte replacement as the mainstay. Specific antimicrobial therapy is reserved for selected infections. Typhoid fever caused by Salmonella typhi or S. paratyphi may be treated with cefixime, ceftriaxone, or quinolones, although resistance is an issue in some regions. Severe enterotoxigenic E. coli and Campylobacter infections may be treated with antibiotics. Cholera requires aggressive rehydration plus doxycycline or tetracycline in adults, or trimethoprim-sulfamethoxazole in young children. Botulism requires prompt antitoxin administration, with botulism immune globulin used in infants. Serious Listeria infections are treated with ampicillin, sometimes combined with gentamicin. Parasitic infections are treated with agents such as metronidazole, nitazoxanide, or trimethoprim-sulfamethoxazole depending on the organism. Noninfectious toxin syndromes are managed supportively, though antihistamines may help in scombroid poisoning and intravenous mannitol has been used for ciguatera.


The prognosis is generally good for most uncomplicated food-borne illnesses, though immunocompromised individuals may have prolonged disease and prolonged shedding of pathogens. Some conditions are life-threatening, especially cholera because of severe dehydration, and tetrodotoxin or paralytic shellfish toxin poisoning because of respiratory paralysis. Complications may also occur, such as temporary lactose intolerance after rotavirus infection, and reactive arthritis or Guillain–Barré syndrome after Campylobacter jejuni infection.

​

Infectious Disease And Microbiology – Filariasis




Filariasis is a tropical parasitic disease caused by thread-like nematode worms of the superfamily Filarioidea. These parasites are transmitted to humans by insect vectors and may live in the lymphatic system, skin, connective tissue, serous cavities, or blood vessels. Adult worms can survive in the human host for more than 20 years, causing chronic disease and disability.


Filariasis includes several distinct syndromes. Lymphatic filariasis, caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori, is endemic in many tropical and subtropical regions of Asia, Africa, South and Central America, and the Pacific. More than one billion people are at risk worldwide, with over 120 million infected and tens of millions suffering from disabling disease. Loiasis is confined mainly to the rainforests of western and central Africa. Onchocerciasis, or river blindness, affects millions in Africa and parts of South America and is a major cause of blindness. Dracunculiasis, or Guinea worm disease, occurs mainly in parts of Africa and Yemen. Dirofilariasis is rare in humans but has worldwide distribution, while mansonelliasis occurs in Africa, the Caribbean, and parts of Central and South America.


Major risk factors include living in or traveling to endemic areas and low socioeconomic status. Prevention depends on health education, vector control, and avoidance of insect bites. Recommended measures include sleeping under mosquito nets, wearing long sleeves, and using insect repellents containing at least 30% DEET. For dracunculiasis, prevention also includes drinking clean or filtered water, preventing infected individuals from entering water sources, and treating contaminated water to kill copepods.


The pathophysiology differs by species. In lymphatic filariasis, adult worms damage lymphatic vessels, causing dilation, valvular dysfunction, lymphatic obstruction, and eventually irreversible lymphedema and elephantiasis. In loiasis, larvae introduced by fly bites migrate beneath the skin, causing transient localized swelling known as Calabar swellings. In onchocerciasis, adult worms form nodules in the skin while microfilariae migrate through skin and eyes, causing dermatitis and blindness. In dracunculiasis, ingested larvae mature and female worms migrate to the skin, typically in the lower limbs, where they emerge through painful ulcers. Dirofilariasis often causes localized granulomatous reactions or pulmonary nodules. In mansonelliasis, dying worms provoke inflammatory responses leading to abscesses or granulomas.


The causative organisms include Wuchereria bancrofti, Brugia species, Loa loa, Onchocerca volvulus, Dracunculus medinensis, Dirofilaria species, and Mansonella species. Each is transmitted by a specific vector, such as mosquitoes, blackflies, midges, red tabanid flies, or infected copepods in water.


The clinical manifestations depend on the species involved. Lymphatic filariasis may cause fever, lymphangitis, lymphadenitis, hydroceles, lymphedema, elephantiasis, epididymitis, and occasionally bronchospasm. Loiasis presents with transient swellings, itching, hives, and migration of the worm across the eye. Onchocerciasis causes subcutaneous nodules, severe itching, skin thickening or pigment changes, lymphadenopathy, and visual loss. Dracunculiasis presents with painful skin ulcers from which the worm emerges. Dirofilariasis may cause cough, chest pain, or hemoptysis. Mansonelliasis may cause fever, swelling, rash, itching, headaches, arthralgia, and neurologic symptoms.


Physical examination findings vary accordingly. In lymphatic filariasis, patients may have lymphadenopathy, hydroceles, enlarged spermatic cord, lower extremity lymphedema, or even arthritis. Loiasis often shows visible Calabar swellings or worms migrating beneath the conjunctiva. Onchocerciasis produces characteristic skin changes and nodules, along with ocular disease. Dracunculiasis reveals a visible white worm emerging from an ulcer, usually on the lower extremity. Mansonelliasis may show pruritus, rash, edema, fever, hepatomegaly, and neurologic signs.


Diagnosis depends on the specific infection. Blood smears may reveal microfilariae in lymphatic filariasis or mansonelliasis. Skin snips or biopsies are useful in loiasis and onchocerciasis. Dracunculiasis is usually diagnosed clinically. Histology may be needed for dirofilariasis. Ultrasound can show adult worms in lymphatic vessels, and imaging such as CT or MRI may detect pulmonary nodules or deep skin nodules. Plain radiographs may reveal calcified Guinea worms.


Treatment depends on the species. In lymphatic filariasis, doxycycline is used to target Wolbachia endosymbionts, followed later by albendazole and ivermectin. Loiasis is treated with diethylcarbamazine. Onchocerciasis is treated with ivermectin, repeated after six months, with prednisone used beforehand if the eyes are involved. Dracunculiasis requires slow mechanical extraction of the worm, sometimes aided by metronidazole or mebendazole. Mansonella species are treated with albendazole or ivermectin depending on the species involved. There is no effective medical therapy for dirofilariasis. In general, treatment is more effective against microfilariae than adult worms, so repeated therapy may be necessary.


Supportive care and specialist referral are often needed. Infectious disease consultation may be helpful, and ophthalmologic assessment is essential in onchocerciasis. Surgical treatment may be required for removal of nodules in onchocerciasis or lung lesions in dirofilariasis. Hospitalization is mainly needed for complications such as septicemia from open wounds.


With timely diagnosis and treatment, disability and disfigurement can often be limited. However, complications can be severe, especially in lymphatic filariasis, where elephantiasis and secondary bacterial infection may occur, and in onchocerciasis, where blindness is a major consequence.

​

​Infectious Disease And Microbiology – Epidemic Pleurodynia (Bornholm Disease)


Epidemic pleurodynia is an acute febrile illness characterized by the sudden onset of severe chest or abdominal pain accompanied by muscle spasms. It is also known as epidemic myalgia or Bornholm disease, named after a Danish island where outbreaks were first described, and is sometimes referred to as “devil’s grip” due to the intensity of pain.


This condition typically occurs in outbreaks, often affecting multiple members of the same household or community either simultaneously or over several days. It is most commonly caused by enteroviruses, particularly coxsackievirus group B, though coxsackievirus A and echoviruses can also be responsible. The disease is more prevalent during late summer and early autumn, coinciding with peak enteroviral transmission. Close contact in settings such as sports fields, locker rooms, or shared drinking containers facilitates person-to-person spread. Children tend to experience milder illness than adults, though infections can also occur in neonates. Intense physical exertion during the incubation period may lead to more severe symptoms.


Prevention focuses on limiting transmission through good hygiene practices. Avoiding shared oral contact, using individual drinking containers, and preventing contamination of shared items such as ice chests are important measures. Education of students, athletes, and staff in group settings can help reduce outbreaks.


The pathophysiology is thought to involve direct viral invasion of skeletal muscles of the thoracic and abdominal wall, leading to inflammation and pain. The most common etiologic agent is coxsackievirus B, although several echoviruses and coxsackievirus A strains have also been implicated.


Clinically, the illness begins abruptly without a prodrome, with fever and severe, intermittent spasms of pleuritic chest or upper abdominal pain. Fever typically rises quickly to 38–39.5°C and subsides as the pain resolves. The pain is sharp, stabbing, and often described as knifelike, lasting 15–30 minutes per episode and associated with sweating and rapid breathing. In adults, chest pain predominates, while children more commonly present with abdominal pain, sometimes mimicking acute surgical conditions. Muscle tenderness is usually present, and a pleural rub may occasionally be heard. The illness generally lasts 4–6 days, although duration may vary.


On physical examination, pain can typically be reproduced by palpation of the affected muscles, and in some cases, localized swelling may be noted. Laboratory findings are usually nonspecific, with a normal white blood cell count. Virologic confirmation can be achieved by isolating the virus from throat swabs or stool samples, or by demonstrating rising antibody titers. Chest imaging is typically normal, although small pleural effusions may rarely be seen.


The differential diagnosis is broad and includes pneumonia, pulmonary embolism, myocardial ischemia, pulmonary infarction, herpes zoster, and causes of acute abdominal pain such as appendicitis or renal colic. Because of its dramatic presentation, careful evaluation is needed to exclude these more serious conditions.


Treatment is primarily supportive. Nonsteroidal anti-inflammatory drugs are the mainstay for pain relief, and application of heat to the affected muscles can provide additional comfort. In severe cases, opiate analgesics may be required. General supportive care is usually sufficient, and no specific antiviral therapy is indicated.


The prognosis is excellent. The illness is self-limited, typically resolving within 4–7 days, and is rarely fatal. Recurrences can occur but are uncommon. Complications are rare but may include aseptic meningitis or orchitis in a small percentage of cases, while pericarditis and pneumonia are even less frequently observed.

​

Infectious Disease And Microbiology – Exanthem Subitum (Roseola Infantum)




Exanthem subitum, also known as roseola infantum or sixth disease, is a common, benign, self-limiting viral illness of early childhood. It is most often caused by human herpesvirus 6B (HHV-6B), although human herpesvirus 7 (HHV-7) may also be responsible.


Epidemiologically, the disease occurs worldwide and primarily affects children between 6 months and 3 years of age, with about 90% of cases occurring before age 2. By the age of 3, nearly all children have been exposed, with antibody prevalence approaching 100%. Maternal antibodies protect infants initially but decline by 6 months, after which susceptibility increases. HHV-7 tends to affect slightly older children and may be associated with a higher risk of febrile seizures.


Human herpesvirus 6B accounts for approximately 10–45% of febrile illnesses in young children. A small proportion of individuals (around 1%) are born with chromosomally integrated HHV-6, though the clinical significance remains unclear.


Currently, there are no specific preventive measures for primary infection. Prophylaxis may be considered in high-risk populations such as bone marrow transplant recipients.


Pathophysiologically, after primary infection, the virus establishes latency in various tissues including lymphoid organs, saliva, and the central nervous system. It infects multiple cell types such as CD4+ T lymphocytes, monocytes, macrophages, endothelial and epithelial cells, and astrocytes. Reactivation can occur, particularly in immunocompromised individuals.


Etiologically, HHV-6 exists as two variants, HHV-6A and HHV-6B, which are now considered distinct viruses. HHV-6 is closely related to cytomegalovirus (CMV). HHV-7 is another causative agent of roseola-like illness.


Clinically, the incubation period is approximately 10–14 days. In children, the disease typically presents with the abrupt onset of high fever (often up to 41°C), lasting 3–5 days. Despite the high fever, the child usually appears relatively well. As the fever subsides, a characteristic maculopapular rash appears in some cases (about 10%), beginning on the trunk and spreading to the face and limbs. The rash is pink, nonpruritic, transient, and resolves within 1–2 days without desquamation.


Associated symptoms may include mild upper respiratory features, cervical lymphadenopathy, and occasionally gastrointestinal symptoms such as diarrhea or vomiting. Febrile seizures occur in about 10% of cases. In infants, a bulging anterior fontanelle may be noted. In rare cases, especially in immunocompromised patients, complications such as encephalitis may occur.


In adults, primary infection or reactivation may present as a mononucleosis-like illness, upper respiratory infection, pneumonia, or hepatitis. In transplant patients, HHV-6 is an important cause of bone marrow suppression and interstitial pneumonitis.


On physical examination, key findings include high fever with abrupt resolution, followed by a transient rash, cervical lymphadenopathy, and generally preserved overall condition.


Laboratory findings may show leukopenia, lymphocytopenia, atypical lymphocytes, and sometimes mild hepatitis, especially in adults. The erythrocyte sedimentation rate is typically normal, and cerebrospinal fluid findings are usually normal unless there is CNS involvement. Diagnosis can be confirmed by PCR, viral isolation, or serology, although routine testing is not usually required in typical cases.


The differential diagnosis includes other viral infections such as CMV, adenovirus, measles, rubella, and viral upper respiratory infections, as well as serious bacterial infections. A key distinguishing feature is the child’s relatively well appearance despite high fever and the appearance of rash after defervescence.


Treatment is supportive in most cases. Antipyretics such as acetaminophen (paracetamol), adequate hydration, and comfort measures are usually sufficient. Antiviral therapy (e.g., ganciclovir or foscarnet) is reserved for severe cases or immunocompromised patients, particularly transplant recipients.


The prognosis is excellent, as the disease is self-limiting. Most children recover completely without complications.


Complications are rare but may include febrile seizures, and in immunocompromised patients, more severe outcomes such as pneumonia, hepatitis, bone marrow suppression, encephalitis, or aseptic meningitis.

​

Infectious Disease And Microbiology – Erythema Nodosum




Erythema nodosum is the most common form of panniculitis, characterized by inflammatory, tender nodules that typically appear on the lower extremities, especially the shins. It represents a reactive process rather than a primary infection and is often associated with a wide range of underlying conditions.


Epidemiologically, erythema nodosum most frequently affects individuals between 18 and 34 years of age and is more common in females. The annual incidence in hospitalized patients has been estimated at 52 cases per million people, with an overall prevalence of about 2.4 per 1,000 population per year. Seasonal clustering has been observed, particularly in cases associated with sarcoidosis, with peaks in late summer and early autumn.


Genetic predisposition has been suggested, especially in sarcoidosis-associated cases, where specific human leukocyte antigens such as HLA-B8 and HLA-DR3 have been implicated.


Pathophysiologically, erythema nodosum is considered a type IV delayed hypersensitivity reaction to various antigens. This immune-mediated process leads to inflammation of the subcutaneous fat, particularly affecting the septa between fat lobules.


The etiology is diverse and includes infectious and noninfectious causes. Among infectious triggers, streptococcal infections (especially group A beta-hemolytic streptococci) are the most common. Other bacterial causes include tuberculosis, brucellosis, and cat-scratch disease. Viral causes include cytomegalovirus, Epstein–Barr virus, HIV, hepatitis B, and herpes simplex virus. Fungal infections such as histoplasmosis and coccidioidomycosis, as well as protozoal infections like toxoplasmosis and amebiasis, have also been implicated.


Noninfectious causes include medications (e.g., sulfonamides and oral contraceptives), malignancies (such as lymphoma and leukemia), and systemic diseases including sarcoidosis, inflammatory bowel disease, Behçet’s disease, lupus erythematosus, and Sjögren’s syndrome. Pregnancy is another recognized trigger. In many cases, however, no cause is identified (idiopathic erythema nodosum).


Clinically, patients present with the sudden onset of painful, erythematous nodules, most commonly on the shins, ankles, and knees. These lesions may be accompanied by systemic symptoms such as fever, fatigue, and joint pain. The nodules evolve over time, changing from bright red to purplish and eventually yellow-green, resembling bruises. Importantly, they do not ulcerate and heal without scarring.


On physical examination, the nodules are tender and raised initially, later becoming flatter as they resolve. They are most commonly located on the anterior lower legs but may also appear on the arms, neck, or face in rare cases.


Diagnosis is largely clinical but supported by investigations aimed at identifying the underlying cause. Laboratory tests include complete blood count, inflammatory markers (ESR), antistreptolysin O titers, throat cultures, and PCR for streptococcal infection. Tuberculosis testing and urinalysis may also be performed. Imaging such as chest X-ray is useful, particularly to detect sarcoidosis (e.g., bilateral hilar lymphadenopathy) or tuberculosis.


Additional diagnostic procedures may include stool studies for gastrointestinal symptoms, skin biopsy (which shows characteristic “Miescher’s radial granulomas”), and further investigations such as colonoscopy or lung biopsy depending on suspected underlying disease.


The differential diagnosis includes other forms of panniculitis such as erythema induratum of Bazin, superficial thrombophlebitis, Lyme disease, and systemic lupus erythematosus.


Management is primarily supportive, as erythema nodosum is usually self-limiting and resolves within a few weeks. Treatment should focus on addressing the underlying cause when identified. Symptomatic relief can be achieved with nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin or naproxen. In more severe cases, corticosteroids (e.g., prednisone) may be used after excluding infections and malignancy. Other therapies, including potassium iodide, hydroxychloroquine, colchicine, or biologics like infliximab, may be considered in specific cases.


General supportive measures include bed rest, leg elevation, and compression therapy to reduce discomfort and inflammation.


The prognosis is generally excellent, with most cases resolving within 3–4 weeks. Recurrence is uncommon but may occur, particularly in idiopathic cases or those associated with recurrent infections.


Complications are rare but may include unusual manifestations such as optic neuritis during acute episodes.

​

Infectious Disease And Microbiology – Epididymitis




Epididymitis is an inflammatory condition of the epididymis, most commonly caused by infection but also occasionally due to noninfectious causes such as trauma, drugs, or systemic diseases. It can be classified as acute or chronic, with chronic epididymitis defined by symptoms lasting more than three months.


Epididymitis is a common urologic condition, particularly in men aged 18–50 years, and is one of the leading causes of scrotal pain in this age group. It shows a bimodal age distribution, affecting younger sexually active men (16–30 years) and older men (51–70 years). It is also more common in men who engage in unprotected anal intercourse. Additional risk factors include bacteriuria, recent urinary tract instrumentation or surgery, prolonged sitting, strenuous physical activity, and conditions such as prostatic obstruction in older men or congenital urinary abnormalities in children.


Prevention focuses mainly on reducing sexually transmitted infections (STIs). This includes abstinence, mutual monogamy with an uninfected partner, and consistent and correct use of latex condoms. These measures significantly reduce the risk of infection-related epididymitis.


The pathophysiology typically involves retrograde ascent of pathogens from the urethra or bladder into the epididymis. Increased voiding pressures and urinary reflux into the vas deferens may contribute, especially in patients with underlying voiding dysfunction such as urethral strictures or bladder outlet obstruction.


The causes of epididymitis vary by age and risk factors. In younger men, the most common causes are sexually transmitted pathogens, particularly Neisseria gonorrhoeae and Chlamydia trachomatis. In older men or those with urinary tract abnormalities, enteric organisms such as Escherichia coli, Klebsiella, Proteus, and Pseudomonas are more common. Less frequently, infections may be caused by organisms such as Mycobacterium tuberculosis, Brucella, fungi, or parasites. Noninfectious causes include vasculitic diseases, medications like amiodarone, trauma, or idiopathic mechanisms. Epididymitis is often associated with orchitis (inflammation of the testis).


Clinically, patients typically present with gradual onset of unilateral scrotal pain and swelling over several days. Pain is usually localized to the posterior aspect of the testis and may radiate to the lower abdomen. Urinary symptoms such as dysuria, frequency, urgency, or hematuria may be present, along with fever and chills. A preceding urethral discharge suggests a sexually transmitted cause. Chronic epididymitis presents with persistent or intermittent discomfort lasting more than six weeks.


On physical examination, there is localized tenderness of the epididymis that may progress to testicular swelling. Urethral discharge may be visible. The cremasteric reflex is usually preserved, which helps distinguish epididymitis from testicular torsion. Pain may improve with elevation of the testis (Prehn’s sign). In advanced cases, reactive hydrocele or scrotal erythema may develop.


Diagnosis involves laboratory and imaging studies. Urethral swabs and urine samples are used to detect infection, including Gram stain, culture, and PCR testing for Chlamydia and Gonorrhea. Urinalysis may show leukocytes or leukocyte esterase. Blood cultures may be useful in severe cases. Inflammatory markers such as CRP and ESR may help differentiate epididymitis from testicular torsion. Color Doppler ultrasonography is the imaging modality of choice and typically shows increased blood flow in the epididymis, helping to exclude torsion, which shows reduced flow.


The main differential diagnosis is testicular torsion, which is a surgical emergency and must always be excluded. Other less common considerations include testicular tumors.


Treatment is primarily medical. Empiric antibiotic therapy should be started promptly based on the most likely pathogens. In sexually transmitted cases, treatment includes a single intramuscular dose of ceftriaxone followed by oral doxycycline for 10 days, or azithromycin as an alternative. In cases due to enteric organisms, fluoroquinolones such as levofloxacin or ofloxacin are commonly used. Supportive measures include bed rest, scrotal elevation, analgesics, and nonsteroidal anti-inflammatory drugs. Patients with HIV are treated similarly, although atypical pathogens may be more common.


Surgical intervention is reserved for complications such as abscess formation, testicular infarction, or pyocele. Hospital admission is required for severe cases with systemic symptoms or suspected bacteremia.


Patient education is essential. Patients with sexually transmitted epididymitis should ensure that their sexual partners are evaluated and treated if exposure occurred within the preceding 60 days. Sexual activity should be avoided until treatment is completed and symptoms have resolved.


Complications include bacteremia, testicular infarction, scrotal abscess, chronic epididymitis, infertility, and formation of a draining sinus. In children, distinguishing epididymitis from testicular torsion is especially important, as torsion is more common and requires urgent surgical management.

​

Emergency and Acute Medicine - Tetanus


Tetanus is a life-threatening neurologic disease caused by a toxin-producing bacterium and is now rare in developed countries but remains common worldwide, particularly in regions with limited vaccination coverage. Although only a small number of cases occur annually in countries like the United States, the disease still carries a high mortality rate. Most cases occur in individuals who are unvaccinated, inadequately immunized, or have not received a booster within the past 10 years. The incubation period typically ranges from 48 hours to several weeks, and a shorter onset period is associated with a worse prognosis. Neonatal tetanus, often resulting from infection of the umbilical stump, remains a major cause of infant mortality in developing regions.


The disease is caused by Clostridium tetani, an anaerobic, spore-forming gram-positive bacterium found in soil and animal feces. Its spores are highly resistant and can survive in harsh environments for long periods. Infection occurs when spores enter a wound or devitalized tissue and germinate under anaerobic conditions. The organism produces tetanospasmin, a potent neurotoxin that interferes with inhibitory neurotransmitters such as GABA, leading to uncontrolled muscle contractions, rigidity, and autonomic dysfunction.


Clinically, tetanus most commonly presents as a generalized form, characterized initially by muscle stiffness and pain, especially involving the jaw (trismus). This progresses to the classic facial expression known as risus sardonicus and generalized muscle rigidity. Patients may develop severe muscle spasms, including opisthotonos (arching of the back), limb rigidity, and clenched fists. Respiratory compromise can occur due to diaphragmatic involvement. Autonomic instability, including fluctuations in blood pressure, arrhythmias, and hyperthermia, is a major cause of death and often develops later in the course.


Other forms include localized tetanus, which causes muscle spasms near the site of injury and may persist for months, and cephalic tetanus, which follows head injuries or ear infections and involves cranial nerve dysfunction. Neonatal tetanus presents in the first weeks of life with poor feeding, irritability, and generalized spasms, and carries an extremely high mortality rate.


Diagnosis is primarily clinical, based on characteristic signs such as trismus and muscle rigidity. Laboratory tests are not diagnostic but may help exclude other conditions or assess complications. Wound cultures for the organism are often negative, and cerebrospinal fluid is typically normal. Differential diagnoses include conditions such as strychnine poisoning, meningitis, encephalitis, dystonic drug reactions, and other causes of muscle rigidity or spasms.


Management requires urgent supportive care and focuses on three main goals: stabilization, neutralization of toxin, and eradication of the organism. Airway management is critical, and early intubation is often necessary due to the risk of respiratory compromise. Muscle spasms are treated with benzodiazepines, and severe cases may require additional agents such as dantrolene or neuromuscular blockade. Autonomic instability is difficult to manage and may require medications such as labetalol, magnesium, or sedatives.


Neutralization of unbound toxin is achieved with tetanus immune globulin, which should be administered as early as possible. However, it does not affect toxin already bound to the nervous system. Elimination of the bacteria is accomplished through wound debridement and antibiotic therapy, with metronidazole being the preferred agent.


Prevention is essential and relies on vaccination. Routine immunization begins in childhood, with booster doses recommended every 10 years. In the setting of wounds, vaccination status must be assessed, and tetanus prophylaxis provided as indicated. Importantly, natural infection does not confer immunity, so patients must still be vaccinated after recovery.


All patients with suspected generalized tetanus require admission to an intensive care unit due to the risk of rapid deterioration and life-threatening complications. Early recognition, aggressive supportive care, and timely administration of immune globulin and antibiotics are critical in improving outcomes.

​

Theophylline poisoning is a potentially life-threatening toxicologic emergency resulting from excessive levels of a methylxanthine drug commonly used for respiratory conditions. Its toxicity is primarily due to increased endogenous catecholamine release, antagonism of adenosine receptors, and inhibition of phosphodiesterase at high concentrations. These mechanisms lead to widespread stimulation of the cardiovascular and central nervous systems. Theophylline is available in both immediate-release and sustained-release formulations, with peak absorption occurring within 1–2 hours for immediate-release and up to 6–10 hours for sustained-release forms, which can delay toxicity.


Toxicity can occur in several patterns. Acute overdose refers to a large ingestion in a patient without prior exposure, whereas acute-on-chronic toxicity occurs when a patient already on therapy takes an excessive dose. Chronic toxicity develops gradually due to accumulation, often from drug interactions, organ dysfunction such as liver disease or heart failure, or repeated dosing errors. Importantly, chronic toxicity tends to cause severe symptoms at lower serum levels compared to acute overdose.


Clinically, theophylline poisoning affects multiple organ systems. Cardiovascular manifestations include sinus tachycardia, atrial and ventricular dysrhythmias, and in severe cases ventricular tachycardia due to β1 stimulation and adenosine antagonism. Hypotension may occur at very high levels due to β2-mediated vasodilation and can be resistant to standard treatments. Neurologically, patients may present with tremors, agitation, altered mental status, and seizures, which are a hallmark of severe toxicity and occur more frequently in chronic intoxication. Gastrointestinal symptoms are common, particularly persistent nausea and vomiting, which can be severe and refractory.


Metabolic abnormalities are also prominent, including hypokalemia due to intracellular potassium shift, hyperglycemia, leukocytosis, and metabolic acidosis with elevated lactate. Hypophosphatemia and hypomagnesemia may also occur. Sustained-release formulations may form pharmacobezoars in the gastrointestinal tract, delaying absorption and prolonging toxicity.


Diagnosis is confirmed by measuring serum theophylline levels, with concentrations ≥20 μg/mL considered toxic. Serial levels are essential to ensure that peak levels have been reached, especially with sustained-release products. Electrocardiographic monitoring is critical due to the high risk of dysrhythmias. Additional laboratory testing helps assess complications such as electrolyte disturbances and metabolic derangements.


Management begins with stabilization of airway, breathing, and circulation, along with cardiac monitoring. Intravenous fluids are administered for hypotension, and rate control for supraventricular tachyarrhythmias may require β-blockers or calcium channel blockers. Notably, adenosine is often ineffective because its action is antagonized by theophylline. Ventricular dysrhythmias are treated according to standard protocols. Seizures should be treated aggressively with benzodiazepines, as other agents such as phenytoin are ineffective and may worsen outcomes.


Gastrointestinal decontamination plays a major role in treatment. Activated charcoal is highly effective, particularly when given in multiple doses, as it enhances elimination by interrupting enterohepatic circulation. Whole-bowel irrigation may be used for sustained-release ingestions to remove unabsorbed drug. Antiemetics such as metoclopramide or ondansetron may be required for severe vomiting. Electrolyte abnormalities should be corrected cautiously, especially hypokalemia, to avoid rebound hyperkalemia as drug levels fall.


In severe cases, extracorporeal removal such as hemodialysis or hemoperfusion is indicated, particularly in patients with very high serum levels, refractory seizures, or significant dysrhythmias. These methods are highly effective due to theophylline’s pharmacokinetic properties.


Patients with severe toxicity, high serum levels, or complications such as seizures or refractory hypotension require intensive care admission. Those with mild symptoms may be discharged once serum levels are clearly decreasing and below toxic thresholds, provided they remain clinically stable. Close follow-up is necessary, especially in patients on chronic therapy, to adjust dosing and prevent recurrence.


A key point in theophylline poisoning is that seizures and tachydysrhythmias are major causes of morbidity and mortality, and early recognition with aggressive treatment significantly improves outcomes. Multi-dose activated charcoal remains one of the most effective interventions in enhancing drug elimination.

​